ORAL ABX464 QD IS EFFICACIOUS AND SAFE DURING PHASE 2B INDUCTION AND MAINTENANCE TREATMENT OF ULCERATIVE COLITIS PATIENTS

Severine Vermeire  1     Paul GINESTE  2     Herbert Tilg  3     Silvio Danese  4     Radoslaw Kempinski  5     Zsolt Tulassay  6     Josianne Nitcheu  6     Sophie Biguenet  6     Hartmut Ehrlich  6     Jean-Marc Steens  6     William Sandborn  7     Bruce E. Sands  8    
1 KU Leuven, Leuven, Belgium
2 Abivax, Paris, France
3 Medical University Innsbruck, Innsbruck, Austria
4 Gastroenterology and Endoscopy and University Vita-Salute, San Raffaele, Milano, Italy
5 Wroclaw Medical University, Wroclaw, Poland
6 Semmelweis University, Budapest, Hungary
7 University of California - San Diego, San Diego, United States
8 Mont Sinai School of Medicine, New York, United States

Topic
IBD

Conference
UEG Week Virtual 2021

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing